What this means
This study is a trial that is recruiting people, so no results have been reported yet. It tests an education plan to help older responders talk with their doctors about stopping medicines they may not need.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50 and over
- Where
- 1 site, including New York
The science
- Registered title
- Improving Medication Management in World Trade Center Responders
- Trial ID
- NCT07022990 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Polypharmacy
- What is tested
- Educational brochure for deprescribing
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Ages
- 50 Years to no maximum
- Dates
- First posted Jun 15, 2025 · updated Jun 15, 2025
Registry summary
By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Sites (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States